SCHEMBL23408646

SCHEMBL23408646

ClC(Cl)(Cl)c1nc(/C=C/c2cnc3ccc(N4CCCC4)nn23)no1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ HSD17B10 Q99714 5/20 0.34
▸ DYRK1A Q13627 4/20 0.33
▸ DYRK2 Q92630 3/20 0.33
▸ DYRK1B Q9Y463 3/20 0.33
▸ DYRK3 O43781 2/20 0.33
▸ CCNT1 O60563 2/20 0.33
▸ CDK9 P50750 2/20 0.33
▸ NPC1 O15118 4/20 0.31
▸ CASP1 P29466 3/20 0.31
▸ RAB9A P51151 3/20 0.31
▸ CASP7 P55210 3/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ TP53 P04637 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ PIM1 P11309 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23408661 0.77 CXCR4 (0.39) HTTSMN1; SMN2TDP1
SCHEMBL23408757 0.77 KDM4E (0.36) HTTSMN1; SMN2HSD17B10NPC1CASP1
SCHEMBL23408587 0.77 NTRK1 (0.53) —
SCHEMBL23408831 0.77 HTT (0.34) HTTSMN1; SMN2TDP1HSD17B10NPC1
SCHEMBL23408832 0.74 KMT2A (0.36) SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL23408637 0.70 HTT (0.43) HTTSMN1; SMN2TDP1HSD17B10DYRK1A
SCHEMBL23408638 0.67 HTT (0.39) HTTSMN1; SMN2TDP1HSD17B10DYRK1A
SCHEMBL24074245 0.63 HTT (0.51) HTTSMN1; SMN2TDP1HSD17B10DYRK1A
SCHEMBL22083655 0.63 HTT (0.55) HTTSMN1; SMN2TDP1HSD17B10DYRK1A
SCHEMBL15258013 0.63 HTT (0.59) HTTSMN1; SMN2TDP1HSD17B10DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021098745-A1 PREPARATION AND APPLICATION OF A CLASS OF PROTEIN RECEPTOR KINASE INHIBITORS 上海轶诺药业有限公司 2021-05-27 — — WO disclosed
Send feedback